Thinking of joining a study?

Register your interest

Become a volunteer?

NCT05984680 | RECRUITING | Chronic Obstructive Pulmonary Disease

COPD Care Pathway Among Patients With Cancer
Sponsor:

Wake Forest University Health Sciences

Brief Summary:

This study gathers information for the development of a COPD care pathway for patients with cancer that reduces the treatment burden of patients, implements critical components of COPD care, and overcomes common barriers to COPD care in the community oncology clinic.

Condition or disease

Chronic Obstructive Pulmonary Disease

Lung Cancer

Head and Neck Cancer

Intervention/treatment

Observational Phase 1

Observational Phase 2, Group I

Observational Phase 2, Group II

Observational Phase 3

Detailed Description:

Primary Objective: To design a feasible COPD care pathway for patients with cancer that reduces the treatment burden of patients, implements critical components of COPD care, and overcomes common barriers to COPD care in the community oncology clinic. Secondary Objectives: * To identify, characterize, and explain the treatment burdens of COPD and cancer as comorbidities, as reported by patients and providers. * To identify, characterize, and explain barriers to COPD care in the oncology clinic, as reported by patients and providers. * To identify, characterize, and explain important and feasible components of COPD care for patients with cancer.

Study Type : OBSERVATIONAL
Estimated Enrollment : 100 participants
Official Title : User-Centered Design of a COPD Care Pathway for Patients With Cancer
Actual Study Start Date : 2025-02-27
Estimated Primary Completion Date : 2026-03
Estimated Study Completion Date : 2026-03

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: 1
Criteria
Inclusion Criteria
  • * The participant has personal experience with medical management of COPD, defined as meeting at least one of the following criteria
    • 1. patient with clinical documentation of COPD (either as a confirmed or suspected diagnosis) and has received at least one dose of an immune checkpoint inhibitor for cancer or
    • 2. provider who currently works at least part-time in a medical oncology clinic or
    • 3. provider who works at least part-time to care for patients with known or suspected COPD.
    • A suspected diagnosis of COPD can be based on finding(s) by history, exam, or radiography (e.g., CT changes such as emphysema, bronchial wall thickening, or mucus plugging). A provider is defined as a physician, advanced practice provider, nurse, or respiratory therapist. Study team members are permitted to participate in the study if they meet eligibility criteria.
    • * Ability to understand and agree to participate on the study as described by the study information sheet.
    • * Capability of speaking or reading English.
    Exclusion Criteria: Severe psychiatric symptoms; unusual social situation; or critical instability that would limit adherence to the study requirements, as determined by the study team.
COPD Care Pathway Among Patients With Cancer

Location Details

NCT05984680

Please Choose a site

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations

RECRUITING

United States, North Carolina

Wake Forest Baptist Comprehensive Cancer Center

Winston-Salem, North Carolina, United States, 27157